Deep Tech Startups
5,913 companies tagged Deep Tech, with their investors and founders.
Power Diamond Systems develops diamond semiconductor power and high-frequency devices, commercializing technology transferred from Waseda University research. The company designs diamond-based device and process technology for practical industrial use in the semiconductor sector.
2 investors
Powerlattice develops integrated voltage regulator (IVR) chiplets for power delivery in high-performance processors and AI systems. The company serves semiconductor manufacturers and system-on-chip (SoC) integrators seeking improved power efficiency solutions.
2 investors
Protagene provides clinical-grade gene therapy analysis services, including AAV/LVV gene therapy evaluation and integration site analysis for the biotech industry.
2 investors
Preferred Networks vertically integrates computer science technologies from semiconductors and computing infrastructure to solutions and applications, developing AI/machine learning systems including the domestically-built large language model PLaMo and the MN-Core AI processor series. The company works with leading firms in industrial robotics, pharmaceuticals, energy, and other sectors to apply advanced computing technology in real-world applications.
2 investors
Prefrontal develops frontier AI models aimed at automating scientific discovery.
2 investors
Princeton Identity develops iris-based biometric identity assurance systems, using its Iris-on-the-Move technology and identity server software to provide multi-factor authentication through a single edge device. Its systems serve organizations such as airports, data centers, banks, government R&D labs, manufacturing, and medical facilities for access control, point of sale, and time and attendance.
2 investors
Proception develops advanced humanoid hands that combine robotics and artificial intelligence to enable dexterous manipulation. The company focuses on solving complex challenges in robotic dexterity and mechanical design.
2 investors
Product Science provides end-to-end orchestration for decentralized foundation model training, coordinating workloads across geo-distributed, heterogeneous hardware (from general-purpose GPUs to ASICs) with configurable data sovereignty. It serves enterprises, research labs, and public institutions, and previously incubated Gonka, a decentralized network for AI training and inference.
2 investors
ProFound Therapeutics identifies previously undiscovered proteins encoded by the human genome and characterizes their biological functions to find new drug targets and therapeutic proteins. The company aims to develop medicines for a range of diseases based on this expanded human proteome.
2 investors
Project Q builds Hydris, an Apache 2.0 open-core control plane that integrates heterogeneous sensors, systems, and effectors across air, land, sea, and space into a single taskable picture and exports to any battle management or C2 system. It also offers a UGS Mission Kit for early warning of RF-silent threats, serving defense and sovereign military operations.
2 investors
Prolynx develops ultra-long-acting therapeutics for obesity and metabolic diseases such as type 2 diabetes, using a hydrogel-based microsphere platform with tunable release linker chemistry to control drug release over extended dosing intervals. Its lead program, PLX-821 (semaglutide), and broader pipeline of dual/triple agonists, amylin-based, and combination therapies are built on this half-life extension delivery architecture.
2 investors
Pronto builds an autonomous haulage system (AHS) that equips haul trucks to operate without a driver, aimed at improving safety, reducing costs, and increasing productivity in off-road and mining environments. The company targets commercial transportation and heavy-haul operations.
2 investors
Prospectral develops next-generation spectral imaging cameras using multimodal and metasurface-mediated sensing for computer vision applications. It combines optical design, semiconductor manufacturing, and computer vision research to build imaging systems for machine perception.
2 investors
Protego Bio is a biotech company developing first-in-class therapies for protein misfolding diseases, including its lead candidate PROT-001 for AL amyloidosis, based on research into pharmacological chaperones. Its work targets patients affected by protein misfolding disorders.
2 investors
Proteina develops single-molecule protein-protein interaction (PPI) detection technology (SPID) that generates real-time, high-resolution data to support therapeutic drug development. The company applies PPI analysis toward precision medicine.
2 investors
ProteoWise develops the Hyperblot benchtop instrument for high-throughput multiplexed proteomics, letting researchers load samples and antibody panels to obtain quantified western-style protein data. It targets life-science researchers working in areas such as neuroscience, cancer, and immunology.
2 investors
Protillion Biosciences develops platform technology for antibody engineering and drug discovery.
2 investors
Proto builds patented holographic display hardware and software that turns physical or existing digital displays into interactive AI agents. The platform supports spatial AI and real-time human interaction.
2 investors
Provolut offers an AI-based web app for protein design that predicts protein evolutions and generates candidate variants from a client's starting dataset, aiming to achieve target protein attributes with far fewer lab experiments than methods like directed evolution or deep mutational scanning. It serves pharma, biotechnology, and research organizations, with on-premises or API deployment options.
2 investors
Proxima is a biotech company developing proximity therapeutics through a drug discovery engine and a structural proteomics data platform.
2 investors
PseudolithIC develops mm-wave RF components including power amplifiers, low-noise amplifiers, and transmit/receive front-ends, using heterogeneous integration of compound semiconductors and silicon. The company targets high-performance RF applications with smaller, scalable solutions.
2 investors
Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.
2 investors
PsiThera is a biotechnology company using computational and physics-based methodsβincluding quantum mechanics, molecular dynamics, machine learning, and simulationβfor mechanism-driven drug design and discovery. Its work spans computational chemistry, immunology, and translational research to advance novel therapeutics.
2 investors
STYLY is a spatial layer platform that enables creators to build and distribute digital content for both public spaces and personal environments in the spatial computing era. The platform hosts over 100,000 creators and more than 200,000 pieces of digital content including art, music, fashion, and videos.
2 investors